Skip to main content

Glenn Jay Jaffe

Robert Machemer M.D. Distinguished Professor of Ophthalmology
Ophthalmology, Vitreoretinal Diseases & Surgery
Box 3802 Med Ctr, Durham, NC 27710
Duke Eye Center, 2351 Erwin Ro, Durham, NC 27710

Scholarly Works - Book sections


Intermediate uveitis

Book section · January 1, 2022 Intermediate uveitis comprises a heterogeneous group of disorders that results in inflammation of the ciliary body, pars plana, and peripheral choroid and often involves the retinal vessels. This inflammation clinically is seen as vitritis, snowballs, and ... Full text Cite

Intermediate uveitis

Book section · January 1, 2012 Full text Cite

Nondegradable intraocular sustained-release drug delivery devices

Book section · January 1, 2006 Nondegradable sustained-release devices can be either matrix or reservoir systems. In matrix systems, the drug is homogeneously dispersed inside the matrix material, and slow diffusion of the drug through the polymatrix material provides sustained release ... Cite

Intraocular sustained-release drug delivery in Uveitis

Book section · January 1, 2006 The main goal in the treatment of uveitis is to eliminate intraocular inflammation and thereby relieve discomfort and prevent visually significant complications such as cataract, cystoid macular edema, and hypotony. When anti-inflammatory drugs are given s ... Cite

Drug delivery for proliferative vitreoretinopathy: Prevention and treatment

Book section · January 1, 2006 Despite improvements in surgical technique, proliferative vitreoretinopathy (PVR) remains a common and significant vision-threatening complication of retinal detachment repair and trauma. A clinically significant form of PVR occurs following approximately ... Cite

Steroids in Macular Disease

Book section · September 27, 2005 Full text Cite

Cystoid Macular Edema

Book section · January 1, 2005 Full text Cite